Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision note updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T19:41:57.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page shows a minor system revision update from v3.4.1 to v3.4.2, with no changes to the study information, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:15:23.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. This appears to be a minor version update with no changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:30.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added the glossary display and updated QC metadata to show Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while removing the older Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T21:28:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. No substantive study details or user-facing features appear affected.
    Difference
    0.1%
    Check dated 2026-01-14T03:44:30.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer/version notes updated: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T20:20:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.